What is NDC 46708-656?

46708-656 is the product NDC for Sumatriptan Succinate, Sumatriptan succinate 4 mg/.5mL injection, listed with the FDA by Alembic Pharmaceuticals Limited. It has 2 package NDCs, shown above in 10- and 11-digit form.

Alembic Pharmaceuticals Limited, NDC labeler code 46708. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Sumatriptan Succinate?

34 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Sumatriptan Succinate NDC 46708-656 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)46708-656Labeler and product segments. Claims need a package NDC.

Product NDC at billing width46708-0656Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
46708-656-01	46708065601	2 SYRINGE in 1 CARTON (46708-656-01) / .5 mL in 1 SYRINGEMarketed from Nov 6, 2025
46708-656-05	46708065605	1 SYRINGE in 1 CARTON (46708-656-05) / .5 mL in 1 SYRINGEMarketed from Nov 6, 2025

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Sumatriptan Succinate
Generic name (nonproprietary): sumatriptan succinate
Active ingredients: Sumatriptan succinate — 4 mg/.5mL
Dosage form: Injection
Route: Subcutaneous
Labeler: Alembic Pharmaceuticals LimitedNDC labeler code 46708
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 213518
Marketing start: Nov 6, 2025
Listing expires: Dec 31, 2026
Other FDA classes: Serotonin 1b Receptor Agonists (Mechanism)Serotonin 1d Receptor Agonists (Mechanism)
Identifiers: Product ID 46708-656_16b7e44d-afa0-4177-80ef-c3ae9a78a4e1SPL ID 16b7e44d-afa0-4177-80ef-c3ae9a78a4e1SPL set ID 16b7e44d-afa0-4177-80ef-c3ae9a78a4e1RxCUI 1657151, 1793916UNII J8BDZ68989
Pharmacologic class: Serotonin-1b and Serotonin-1d Receptor Agonist

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

Administration

Drug administration (CPT 96360–96549)

When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.

How CPT relates to drug billing

NDC on a medical claim

N446708065601 followed by a unit qualifier and the quantity

Package 46708-0656-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Nov 17, 2025.

Indications (excerpt from the label)

Sumatriptan injection is indicated in adults for (1) the acute treatment of migraine, with or without aura, and (2) the acute treatment of cluster headache. Limitations of Use: Use only if a clear diagnosis of migraine or cluster headache has been established. If a patient has no response to the first migraine or cluster headache attack treated with sumatriptan injection, reconsider the diagnosis before sumatriptan injection is administered to treat any subsequent attacks. Sumatriptan injection is not indicated for the prevention of migraine or cluster headache attacks. SUMATRIPTAN injection, for subcutaneous use Sumatriptan injection is a serotonin (5-HT1B/1D) receptor agonist (triptan) ind…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 46708-656

What is NDC 46708-656?: 46708-656 is the product NDC for Sumatriptan Succinate, Sumatriptan succinate 4 mg/.5mL injection, listed with the FDA by Alembic Pharmaceuticals Limited. It has 2 package NDCs, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Sumatriptan Succinate.
What is the active ingredient?: Sumatriptan succinate.
Who is the labeler?: Alembic Pharmaceuticals Limited, NDC labeler code 46708. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Sumatriptan Succinate?: 34 other product NDCs are listed under this name. See all Sumatriptan Succinate NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Sumatriptan Succinate NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Sumatriptan Succinate	Sumatriptan succinate 4 mg/.5mL	InjectionSubcutaneous	Alembic Pharmaceuticals Inc.	62332-656	62332-0656-0162332-0656-05
Sumatriptan Succinate	Sumatriptan succinate 6 mg/.5mL	InjectionSubcutaneous	Alembic Pharmaceuticals Inc.	62332-657	62332-0657-0162332-0657-05
Sumatriptan Succinate	Sumatriptan succinate 6 mg/.5mL	InjectionSubcutaneous	Alembic Pharmaceuticals Limited	46708-657	46708-0657-0146708-0657-05
Sumatriptan Succinate	Sumatriptan succinate 6 mg/.5mL	InjectionSubcutaneous	Sun Pharmaceutical Industries, Inc.	47335-276	47335-0276-4047335-0276-41
Sumatriptan Succinate	Sumatriptan succinate 25 mg/1	Tablet, Film coatedOral	Direct_Rx	72189-596	72189-0596-09
Sumatriptan Succinate	Sumatriptan succinate 6 mg/.5mL	InjectionSubcutaneous	NorthStar Rx LLC	72603-141	72603-0141-02
Sumatriptan Succinate	Sumatriptan succinate 6 mg/.5mL	InjectionSubcutaneous	Sportpharm LLC	85766-238	85766-0238-02
Sumatriptan Succinate	Sumatriptan succinate 6 mg/.5mL	InjectionSubcutaneous	Dr. Reddys Laboratories Inc.,	43598-768	43598-0768-23
Sumatriptan Succinate	Sumatriptan succinate 25 mg/1	Tablet, Film coatedOral	Direct_Rx	72189-432	72189-0432-09
Sumatriptan Succinate	Sumatriptan succinate 50 mg/1	Tablet, Film coatedOral	Direct_Rx	72189-433	72189-0433-09

All 35 Sumatriptan Succinate NDCs

Other NDCs under ANDA 213518

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 213518
Product	Strength	Form · route	Labeler	Product NDC
Sumatriptan Succinate	Sumatriptan succinate 4 mg/.5mL	InjectionSubcutaneous	Alembic Pharmaceuticals Inc.	62332-656
Sumatriptan Succinate	Sumatriptan succinate 6 mg/.5mL	InjectionSubcutaneous	Alembic Pharmaceuticals Inc.	62332-657
Sumatriptan Succinate	Sumatriptan succinate 6 mg/.5mL	InjectionSubcutaneous	Alembic Pharmaceuticals Limited	46708-657